Propanc Biopharma, Inc. (PPCB) short interest & options flow
NASDAQPPCB (Propanc Biopharma) faces its May 22 earnings report after a bruising month — down 28% over thirty days and 11% on the week alone, with its RSI-14 at a deeply oversold 27.7. The price slide dominates the setup here. At $2.01 per share, the stock has given back most of its gains from earlier in the year, and the selling has been persistent rather than episodic — the momentum…
PPCB short interest collapses 96% in one day to 0.17% of float, falling from 560K shares.
- Market cap
- $1M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026
Latest signals on PPCB
- Short Interest
PPCB short interest collapses 96% in one day to 0.17% of float, falling from 560K shares.
PPCB news and analysis
RSSNo long-form analysis yet for PPCB. Pulse alerts and the live data picture are available on ORTEX.
Open PPCB on ORTEX →Want the live picture for PPCB?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PPCB — free to start on ORTEX.
Sign up for free →Open PPCB on ORTEX